Oncogenicity studies of piperonyl butoxide in rats and mice

Human and Experimental Toxicology

Volumn 17, Issue 6, 1998, Pages 323-330

  Butler, W H ^a   Gabriel, K L ^a   Osimitz, T G ^b   Preiss, F J ^c  

^a Glebe Cottage ^*  (United States)

^b S C Johnson & Son Inc   (United States)

^c McLaughlin Gormley King Co   (United States)

Author keywords

Carcinogenicity; Hepatocellular hypertrophy; Piperonyl butoxide

Indexed keywords

MIXED FUNCTION OXIDASE; PIPERONYL BUTOXIDE;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; HYPERTROPHY; LIVER CELL; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID HYPERPLASIA;

ADENOMA, LIVER CELL; ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; CARCINOGENICITY TESTS; CARCINOGENS; EATING; FEMALE; HYPERPLASIA; HYPERTROPHY; LIVER; LIVER NEOPLASMS; MALE; MICE; ORGAN SIZE; PESTICIDE SYNERGISTS; PIPERONYL BUTOXIDE; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE; THYROID GLAND;

EID: 0031828386     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/096032798678908846     Document Type: Article

References (25)

1. Franklin MR. Inhibition of hepatic oxidation xenobiotic metabolism by piperonyl butoxide. Biochemical Pharmacology 1972; 21: 3287-3299.
2. Lake BG et al. The influence of some hepatic enzyme inducers and inhibitors on extra hepatic drug metabolism. Drug Methods and Disposition 1973; 1: 343-349.
3. Phillips JC et al. Effect of piperonyl butoxide on cell replication and xenobiotic metabolism in the livers of CD-1 mice and F344 rats. Fundamental Applied Toxicology 1997; 38: 64-74.
4. Butler WH, Gabriel KL, Preiss FJ, Osimitz TG. Lack of genotoxicity of Piperonyl Butoxide. Mutation Res 1996; 371: 249-258.
5. Beamand JA et al. Lack of effect of piperonyl butoxide on unscheduled DNA synthesis in Precision-cut human liver slices. Mutation Res 1996; 371: 273-282.
6. - mouse lymphoma cell forward mutation assay III, 72 coded chemicals. Environ Mol Mutagenesis 1988; 12: 85-154.
7. Sarles MP, Vandegrift WB. Chronic toxicity and related studies on animals with the insecticide and pyrethrum synergist, piperonyl butoxide. Am J Trop Med 1952; 1: 862-883.
8. Cardy RH, Renne RA, Warner JW, Cypher RL. Carcinogenesis bioassays of technical-grade piperonyl butoxide in F344 rats. J Natl Cancer Inst 1979; 62: 569-578.
9. Innes JRM et al. Bioassays of pesticides and industrial chemicals for tumorigenicity in mice: A preliminary note. J Natl Cancer Inst 1969; 42: 1101-1114.
10. Maekawa A et al. Lack of evidence of carcinogenicity of technical grade piperonyl butoxide in F344 rats: selective induction of ileocecal ulcers. Food Chem Toxicol 1985; 23: 675-682.
11. Takahashi O et al. Chronic toxicity studies of piperonyl butoxide in F344 rats: Induction of hepatocellular carcinoma. Fundam Appl Toxicol 1994; 22: 2293-2303.
12. Takahashi O et al. Piperonyl butoxide induces hepatocellular carcinoma in male CD-1 mice. Arch Toxicol 1994; 68: 467-469.
13. Gart JJ, Ghu KC, Tarone RE. Statistical issues in the interpretation of chronic bioassay tests for carcinogenicity. J Natl Cancer Inst 1979; 62: 957-974.
14. Evans JG et al. The histology and development of hepatic nodules in C3H/He mice following chronic administration of phenobarbitone. Carcinogenesis 1986; 7: 627-651.
15. Evans JG, Collins MA, Lake BG, Butler WH. The histology and development of hepatic nodules and carcinomas in C3H/He and C57BL/6 mice following phenobarbitone administration. Toxicol Path 1992; 20: 585-594.
16. Jones G, Butler WH. Morphology of spontaneous and induced neoplasia. In: Mouse Hepatic Neoplasia. WH Butler, PM Newberne, (Eds.), Elsvier: Amsterdam, 1975, pp. 21-59.
17. Butler WH. A review of the hepatic tumors related to mixed-function oxidase induction in the mouse. Toxicol Path 1996; 24: 484-492.
18. Ito N et al. Reversibility and irreversibility of liver tumors in mice induced by the isomer of 1,2,3,4,5,6-hexachlorocyclohexane. Cancer Res 1976; 36: 2227-2234.
19. Malarkey DE, Devereux TR, Dime GE, Maronpot RR. Hepatocarcinogenicity of chlordane in B6C3F1 and B6D 2F1 male mice. Evidence for regression in B6C3F1 mice and carcinogenesis independent of ras proto-ongogene activation. Carcinogenesis 1995; 16: 2617-2625.
20. Rumsby PC, Barrass NC, Phillimore HE, Evans JG. Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone. Carcinogenesis 1991; 12: 2331-2336.
21. Fox TR et al. Mutational analysis of the H-ras oncogene in spontaneous C57BL/6X C3H/He mouse liver tumors and tumors induced with genotoxic and non-genotoxic hepatocarcinogens. Cancer Res 1990; 50: 4014-4018.
22. Pedrick MS et al. Growth characteristics and Haras mutations of cell cultures isolated from chemically induced mouse liver tumours. Carcinogenesis 1994; 15: 1847-1852.
23. McClain RM. The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: Implications for thyroid gland neoplasia. Toxicol Path 1989; 17: 294-303.
24. Fujitani T, Tada Y, Yoneyama M. Hepatotoxicity of piperonyl butoxide in male F344 rats. Toxicology 1993; 84: 171-183.
25. National Cancer Institute. Bioassay of piperonyl butoxide for possible carcinogenicity. US Department of Health and Welfare. DHEW Publ. No. 79. p. 1375.